Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Netwerk
Projecten
- 2 Afgelopen
-
ANI194: MYRAGE: Ontwikkeling van een platform voor het testen van myeloïde regelgevende cel targeting agents.
1/05/18 → 31/10/18
Project: Fundamenteel
-
IWT676: Van Myeloïde afkomstige suppressorcellen als een nieuw therapeutisch doelwit bij colorectale kanker
1/01/14 → 10/04/18
Project: Fundamenteel
Onderzoeksoutput
-
Early interim results from a randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in non-small cell lung cancer (NSCLC)
Tijtgat, J., Schwarze, J. K., Vandenbroucke, F., Ilsen, B., Tuyaerts, S., Dufait, I., Decoster, L., De Ridder, M. & Neyns, B., 22 sep 2022.Onderzoeksoutput: Poster
-
Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions
Van de Gucht, M., Dufait, I., Kerkhove, L., Corbet, C., de Mey, S., Jiang, H., Law, K. L., Gevaert, T., Feron, O. & De Ridder, M., okt 2022, In: Cancers. 14, 20, 17 blz., 5060.Onderzoeksoutput: Article › peer review
Open Access -
Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
Schwarze, J. K., Tijtgat, J., Awada, G., Cras, L., Vasaturo, A., Bagnall, C., Forsyth, R., Dufait, I., Tuyaerts, S., Van Riet, I. & Neyns, B., sep 2022, In: Journal for immunotherapy of cancer. 10, 9, blz. 1-13 13 blz., e005141.Onderzoeksoutput: Article › peer review
Open Access -
Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1+ Myeloid Dendritic Cells
Kalus, P., De Munck, J., Vanbellingen, S., Carreer, L., Laeremans, T., Broos, K., Dufait, I., Schwarze, J. K., Van Riet, I., Neyns, B., Breckpot, K. & Aerts, J., mei 2022, In: International Journal of Molecular Sciences. 23, 9, 17 blz., 4865.Onderzoeksoutput: Article › peer review
Open Access1 Citaat (Scopus) -
Sulfasalazine radiosensitizes hypoxic colorectal cancer cells through the inhibition of xCT.
Kerkhove, L., Dufait, I., De Ridder, M., de Mey, S., Geirnaert, F., Law, K. L., Vandenplas, H. & Gevaert, T., mei 2022, In: Radiotherapy and Oncology. 170, blz. S116-S116Onderzoeksoutput: Meeting abstract (Journal)
Activiteiten
-
A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+ / CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
Julia Katharina Schwarze (Presenter), Jens Tijtgat (Contributor), Gil Awada (Contributor), Louise Cras (Contributor), Inès Dufait (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor) & Bart Neyns (Contributor)
17 sep 2021Activiteit: Talk or presentation at a conference
-
Miltenyi Immuno-oncology day
Inès Dufait (Participant)
31 jan 2020Activiteit: Participating in or organizing a public lecture/debate
-
BACR Annual Meeting 2020
Inès Dufait (Organiser), Sven Luk De Mey (Organiser), Kathleen Leemans (Organiser) & Mark De Ridder (Chair)
7 feb 2020Activiteit: Participating in or organizing a public lecture/debate
-
-
Scriptie
-
Myeloid-derived suppressor cells as a novel therapeutic target in colorectal cancer.
Auteur: Dufait, I., De Ridder, M., Breckpot, K., Van Ginderachter, J., Menu, E. & Neyns, B., 19 dec 2018Begeleider: Breckpot, K. (Promotor), De Ridder, M. (Promotor), Van Ginderachter, J. (Jury), Menu, E. (Jury), Neyns, B. (Jury), Smits, E. (Externe persoon) (Jury) & Kochan, G. (Externe persoon) (Jury)
Scriptie/Masterproef: Doctoral Thesis